BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 17906642)

  • 1. RAR and RXR modulation in cancer and metabolic disease.
    Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR; Bourguet W; Altucci L; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoid receptors and therapeutic applications of RAR/RXR modulators.
    le Maire A; Alvarez S; Shankaranarayanan P; Lera AR; Bourguet W; Gronemeyer H
    Curr Top Med Chem; 2012; 12(6):505-27. PubMed ID: 22242853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
    Le Q; Dawson MI; Soprano DR; Soprano KJ
    Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
    Lefebvre P
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):153-64. PubMed ID: 12476796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
    Ahuja HS; Szanto A; Nagy L; Davies PJ
    J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective RXR modulators for the treatment of type II diabetes.
    Faul MM; Grese TA
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):974-85. PubMed ID: 12478728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of oncogenic transformation in acute promyelocytic leukemia: the hetero-union makes the force.
    Minucci S; Pelicci PG
    Cancer Cell; 2007 Jul; 12(1):1-3. PubMed ID: 17613430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diphenylamine-based retinoid antagonists: regulation of RAR and RXR function depending on the N-substituent.
    Ohta K; Kawachi E; Fukasawa H; Shudo K; Kagechika H
    Bioorg Med Chem; 2011 Apr; 19(8):2501-7. PubMed ID: 21459577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoids: potential in cancer prevention and therapy.
    Clarke N; Germain P; Altucci L; Gronemeyer H
    Expert Rev Mol Med; 2004 Nov; 6(25):1-23. PubMed ID: 15569396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective retinoic acid receptor ligands for rheumatoid arthritis.
    Beehler BC; Brinckerhoff CE; Ostrowski J
    Curr Opin Investig Drugs; 2004 Nov; 5(11):1153-7. PubMed ID: 15573865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic applications for ligands of retinoid receptors.
    Thacher SM; Vasudevan J; Chandraratna RA
    Curr Pharm Des; 2000 Jan; 6(1):25-58. PubMed ID: 10637371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of RXR function through ligand design.
    Pérez E; Bourguet W; Gronemeyer H; de Lera AR
    Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic retinoids: structure-activity relationships.
    Barnard JH; Collings JC; Whiting A; Przyborski SA; Marder TB
    Chemistry; 2009 Nov; 15(43):11430-42. PubMed ID: 19821467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.
    García J; Khanwalkar H; Pereira R; Erb C; Voegel JJ; Collette P; Mauvais P; Bourguet W; Gronemeyer H; de Lera AR
    Chembiochem; 2009 May; 10(7):1252-9. PubMed ID: 19343742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the expression patterns of newly identified zebrafish retinoic acid and retinoid X receptors.
    Waxman JS; Yelon D
    Dev Dyn; 2007 Feb; 236(2):587-95. PubMed ID: 17195188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular interaction of retinoic acid receptors with coregulators PCAF and RIP140.
    Chen Y; Hu X; Wei LN
    Mol Cell Endocrinol; 2004 Oct; 226(1-2):43-50. PubMed ID: 15489004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
    Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
    Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13-cis-retinoic acid alters the cellular morphology of slice-cultured serotonergic neurons in the rat.
    Ishikawa J; Sutoh C; Ishikawa A; Kagechika H; Hirano H; Nakamura S
    Eur J Neurosci; 2008 May; 27(9):2363-72. PubMed ID: 18445226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity.
    Farooqui M; Franco PJ; Thompson J; Kagechika H; Chandraratna RA; Banaszak L; Wei LN
    Biochemistry; 2003 Feb; 42(4):971-9. PubMed ID: 12549917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.